Altimmune to present pemvidutide clinical data at the upcoming aha scientific sessions and aasld the liver meeting®

Gaithersburg, md., oct. 28, 2022 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that the company will be presenting at two upcoming scientific conferences in november 2022:
ALT Ratings Summary
ALT Quant Ranking